Marcel Madej

13PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesMolecular targetsCancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 13, 2026
Targeting β-Adrenergic Signaling in Colorectal Cancer: Molecular Mechanisms and Therapeutic Potential of β-Blockers.

|Mar 28, 2026
Phosphoramidate Derivatives of Betulin, New Molecules with Promising Biological Activity: Synthesis and Characterization.

Elwira Chrobak, Marta Świtalska, Marcel Madej

|Jan 28, 2026
Mesalazine Regulates DUSP1, DUSP4, and DUSP5 Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence.

Marcel Madej, Ilona Nowak, Barbara Strzałka-Mrozik

|Nov 27, 2025
CRISPR Genome Editing in Personalized Therapy for Oral and Maxillofacial Diseases: A Scoping Review.

Arkadiusz Dziedzic, Robert Kubina, Magdalena Skonieczna

|Jul 23, 2025
Mesalazine and Lactoferrin as Potential Adjuvant Therapy in Colorectal Cancer: Effects on Cell Viability and Wnt/β-Catenin Pathway.

Joanna Słoka, Marcel Madej, Ilona Nowak

|Jul 12, 2025
Time-Dependent Impact of Betulin and Its Derivatives on IL-8 Expression in Colorectal Cancer Cells with Molecular Docking Studies.

Marcel Madej, Adrianna Halama, Elwira Chrobak

Pageof 3

Frequent Collaborators

6 joint publications

Barbara Strzalka-Mrozik

5 joint publications

Joanna Magdalena Gola

4 joint publications

Elwira Chrobak

4 joint publications

Ilona Nowak